Skip to main navigation Skip to search Skip to main content

Preoperative integrated oxidative stress score as a prognostic factor for predicting clinical outcomes in breast cancer patients received neoadjuvant chemotherapy: a real-world retrospective study

  • Li Chen
  • , Caixia Dai
  • , Shu Peng
  • , Hao Dong
  • , Xiangyu Wang*
  • , Yanfei Liu*
  • , Jing Wang*
  • *Corresponding author for this work
  • Chinese Academy of Medical Sciences - Peking Union Medical College
  • Huazhong University of Science & Technology
  • Wuhan University of Science & Technology

Research output: Contribution to journal › Article › peer-review

Abstract

Objective: The current study aims to investigate the prognostic value of breast cancer integrated oxidative stress score (BCIOSS) in patients with breast cancer who received neoadjuvant chemotherapy (NACT). Methods: A retrospective analysis of 104 breast cancer patients who underwent NACT from June 2009 to December 2015 was performed. The differences of BCIOSS of breast cancers in regard to variables were analyzed using Chi-square test and Fisher's exact test. The Kaplan-Meier method was used to evaluate survival curve between low BCIOSS group and high BCIOSS group, and the two groups were compared by Log-rank tests at the individual index level. The univariate and multivariate Cox regression analyses were established by the important predictive factors determined based on univariate analysis. The nomograms were further conducted based on the factors by the multivariate analyses. Results: Patients were assigned to low BCIOSS group (BCIOSS 2.54) via ROC curve. BCIOSS was a latent prognostic factor for patient survival [DFS; hazard ratio (HR): 0.163, 95%CI: 0.045-0.596, P=0.006; and OS; HR: 0.168, 95%CI: 0.056-0.500, P=0.001]. Patients with a high BCIOSS had longer survival time than those with a low BCIOSS (DFS: chi(2)=7.317, P=0.0068; and OS: chi(2)=9.407, P=0.0022). Calibration curves shown that the predicted line conformed well to the reference line for the 5-year survival category. DCA revealed that the nomograms conducted had a better clinical predictive application than only by BCIOSS. Conclusion: BCIOSS is a latent prognostic factor, and patients with high oxidative stress scores have a better prognosis and longer survival time.
Original languageEnglish
Pages (from-to)1437-1449
Number of pages13
JournalInternational Journal of Medical Sciences
Volume22
Issue number6
DOIs
StatePublished - Jan 2025

Funding

This work was partly supported by research grants from the National Natural Science Foundation of China (No.82173328, No.82371842, No.82473205) by Jing Wang and Xiangyu Wang, Hubei Province Postdoctoral Innovation Research Post Fund Project (No.0106540096) by Li Chen, Open Fund for the Key Laboratory of Organ Transplantation of Ministry of Education and National Health Commission (No.2021QYKF03) by Li Chen, Tongji Hospital Cultivation Project (No.2022B03) by Li Chen, Chen Xiao-ping Foundation for the Development of Science and Technology of Hubei province, Youth Science Special Fund (No.CXPJJH123001-2308) by Li Chen.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • breast cancer
  • breast cancer integrated oxidative stress score
  • neoadjuvant chemotherapy
  • nomogram
  • survival

Indexed by

  • SCIE
  • Scopus

Fingerprint

Dive into the research topics of 'Preoperative integrated oxidative stress score as a prognostic factor for predicting clinical outcomes in breast cancer patients received neoadjuvant chemotherapy: a real-world retrospective study'. Together they form a unique fingerprint.

Cite this